Literature DB >> 2907065

[No Parkinsonian syndrome following acute paraquat poisoning].

T Zilker1, F Fogt, M von Clarmann.   

Abstract

Paraquat structurally resembles N-methyl-4-phenyltetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridine (MPP+). MPTP and MPP+ are neurotoxic chemicals, which induce in exposed humans and in animal-models a Parkinson's disease. A high correlation between the incidence of Parkinson's disease and herbicide use in Canada led to the assumption that paraquat could give rise to parkinsonism. We have therefore carried out a follow-up study with patients having had dermal contact with paraquat or having swallowed paraquat accidentally or in a suicidal attempt. 7 patients took part in the study. Three of them had dermal contact. One had ingested paraquat by accident and three were survivors from suicidal paraquat intake. It was possible to exclude parkinsonism in all patients. One patient exhibited tardive dykinesia most likely due to a long term therapy with neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907065     DOI: 10.1007/BF01727849

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  19 in total

1.  [Treatment of Parkinson disease].

Authors:  C Schlagmann; J Remien
Journal:  Klin Wochenschr       Date:  1986-10-01

2.  Environmental toxins in Parkinson's disease.

Authors:  P Vieregge; D Kömpf; H Fassl
Journal:  Lancet       Date:  1988-02-13       Impact factor: 79.321

3.  Parkinsonism and industrial chemicals.

Authors:  L J Chapman; H A Peters; C G Matthews; R L Levine
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

4.  Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  A Barbeau; M Roy; J W Langston
Journal:  Lancet       Date:  1985-03-30       Impact factor: 79.321

5.  Production in nature of compound resembling methylphenyltetrahydropyridine, a possible cause of Parkinson's disease.

Authors:  D B Ramsden; A C Williams
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

6.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  J W Langston; P A Ballard
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

7.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

8.  Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.

Authors:  D B Calne; J W Langston; W R Martin; A J Stoessl; T J Ruth; M J Adam; B D Pate; M Schulzer
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

9.  MPTP, impairment of motor performance and amine accumulation in Macaca fascicularis.

Authors:  G L Willis; J Savulescu; M K Horne; G C Smith
Journal:  Brain Res Bull       Date:  1987-07       Impact factor: 4.077

10.  [Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].

Authors:  T Brücke; P Riederer
Journal:  Wien Med Wochenschr       Date:  1986-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.